MARKET

RGTLF

RGTLF

Argent BioPharma
OTCPK
0.025
NaN%
Closed 09:30 11/13 EST
OPEN
--
PREV CLOSE
0.025
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
13.50
52 WEEK LOW
0.013
MARKET CAP
2.95M
P/E (TTM)
-0.4065
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGTLF last week (1102-1106)?
Weekly Report · 4d ago
Weekly Report: what happened at RGTLF last week (1026-1030)?
Weekly Report · 11/02 09:49
Argent BioPharma Licenses Non-Core Cannabis Genetics in Global Deal with Thai Phytomed
TipRanks · 10/26 22:12
Weekly Report: what happened at RGTLF last week (1019-1023)?
Weekly Report · 10/26 09:49
Argent Biopharma sharpens immune focus and monetises CannEpil with new licensing deals
TipRanks · 10/22 21:40
Weekly Report: what happened at RGTLF last week (1012-1016)?
Weekly Report · 10/19 09:49
Argent BioPharma Sets November Date for Annual General Meeting
TipRanks · 10/19 07:11
Argent BioPharma Sets AGM Date and Director Nomination Deadline
TipRanks · 10/14 04:57
More
About RGTLF
Argent BioPharma Limited is a clinical-stage biopharmaceutical company pioneering nano-engineered therapeutics that reset the balance between the nervous and immune systems. The Company’s assets, CannEpil and CimetrA, target immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders, respectively. The Company’s proprietary delivery technologies enhance penetration across the blood-brain and alveolar-capillary barriers, supporting differentiated efficacy and composition-of-matter protection. It focuses on urgent unmet needs in the central nervous system (CNS) and systemic inflammation. Its product pipeline includes CimetrA, CannEpil, CogniCann and others. CannEpil is a refractory epilepsy seizure control treatment. CogniCann is an investigational oral spray developed by the Company to help manage symptoms associated with dementia and Alzheimer’s disease. The Company has a patient base in Australia, the United Kingdom, Brazil, and Ireland.

Webull offers Argent BioPharma Ltd stock information, including OTCPK: RGTLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGTLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGTLF stock methods without spending real money on the virtual paper trading platform.